Actemra 80mg - SW (Tocilizumab Vials) 80mg/4ml

Actemra 80mg SW is a prescription injectable containing tocilizumab, used to treat inflammatory conditions like rheumatoid arthritis. This vial form delivers 80mg per 4ml dose for subcutaneous administration. Tocilizumab helps reduce inflammation and manage symptoms in approved autoimmune disorders.

Strength

80mg/4ml

Manufacturer / TM Owner

Roche Pharma Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Actemra 80mg SW with tocilizumab is prescribed to reduce inflammation and manage symptoms in adults with moderate to severe rheumatoid arthritis. It is also used for giant cell arteritis and certain forms of juvenile idiopathic arthritis. Tocilizumab works by blocking interleukin-6 receptors to help control immune responses.

Side Effects

Users of Actemra 80mg SW may experience reduced joint pain and swelling as inflammation decreases. Some report improved mobility and daily function over time with consistent use. The medication’s effects vary by individual and condition being treated.

Precautions & Warnings

Store Actemra 80mg SW vials refrigerated between 2°C and 8°C and protect from light. Do not freeze or shake vigorously. Inspect the solution for particles or discoloration before use. Keep out of reach of children and pets.

Avoid Interactions

Actemra 80mg SW may interact with other biologics or immunosuppressants, increasing infection risk. Caution is advised when combining with live vaccines or CYP450 substrates. Always inform healthcare providers about all medications, including over-the-counter and herbal products.

Frequently Asked Questions

Actemra 80mg SW is used to treat rheumatoid arthritis and certain other inflammatory conditions in adults and children.

Actemra 80mg SW is given as a subcutaneous injection, typically by a healthcare professional or self-injected after proper training.

Common side effects may include injection site reactions, headache, and upper respiratory infections.

Actemra 80mg SW requires a prescription and is available through licensed pharmacies and healthcare providers.

Safety during pregnancy should be discussed with a healthcare provider, as effects may vary by individual circumstances.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.